NCT03955458View on ClinicalTrials.gov

EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 26, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Hip FracturesIntertrochanteric Fractures
Interventions
DRUG

EXPAREL

FICB with EXPAREL + Bupivacaine HCL (single dose)

DRUG

Ropivacaine

FICB with continuous infusion of ropivacaine

DRUG

Bupivacaine Hydrochloride

FICB with EXPAREL + Bupivacaine HCL (Single dose)

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT03955458 - EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture | Biotech Hunter | Biotech Hunter